Jabra OTC Hearing Enhancement Earbuds to Hit Care Clinics Feb. 25: GN

Anticipating finalization of the proposed rule from the Food and Drug Administration to create a category of over-the-counter hearing aids (see 2112060002), GN Hearing announced the Feb. 25 availability of hearing-enhancement earbuds under the Jabra brand. Citing the FDA’s proposed rule to introduce an OTC hearing aid category, GN Hearing CEO Gitte Aabo said Tuesday it will “allow greater access and more affordable hearing treatment options.” The Jabra Enhance Plus earbuds, for iPhones only, have advanced hearing technology for people with mild-to-moderate hearing loss, said the company. They will be sold in select hearing care clinics for $799, it said, noting professional services required by state laws, including hearing tests, aren’t included in the cost. Battery life is given as 10 hours. The earbuds have been 510(k)-cleared with the FDA under the self-fit hearing aid regulation, the company said.